News

The fund will support biotech start-up companies that have the potential to provide innovative products in Merck Serono’s core therapeutic areas, in particular in neurodegenerative diseases, oncology and

Sepracor markets eszopiclone in the US under the brand name Lunesta. The lawsuit alleges infringement of Sepracor’s US patents. Due to the commencement of this litigation, abbreviated new

The study will examine the availability and existing sources of medicines, patient purchasing patterns, and the level of access to medical services. The study ultimately aims to help

Mr Engle has broad management and financial background including six years at Dey LP, where he was the firm’s president and CEO. Mr Engle’s background also includes senior

According to Covidien, the OxiMax SPD feature enables the pulse oximeter to detect and alert clinicians of worrisome oxygen desaturation patterns, allowing them to make timely and more

Dalton Medicinal Chemistry will apply their proprietary insights to the design and synthesis of new classes of compounds against selected Riboswitch targets. BioRelix will advance these compounds with

“As CDEX overcame the scientific hurdles associated with our product lines, two years ago we agreed that I would transition to a support role for the company allowing

Daiichi Sankyo brought patent infringement actions in Tokyo District Court against seven generics companies: Shiono Chemical Co, Taiyo Yakuhin Co, Takata Seiyaku Co, Nichi-Iko Pharmaceutical Co, Nihon Generic

In the US several patients with cancer have now been treated with the company’s survivin inhibitor, which is jointly developed by Santaris Pharma and Enzon Pharmaceuticals. The FDA